Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 181 – 200 of 3231

Updated Contact Information for HIVinfo

https://clinicalinfo.hiv.gov/news/updated-contact-information-hivinfo

Información de Contacto Actualizada para HIVinfo

https://clinicalinfo.hiv.gov/news/updated-contact-information-hivinfo

Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

https://clinicalinfo.hiv.gov/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-3

Actualizaciones de las Guías para la prevención y el tratamiento de infecciones oportunistas en adultos y adolescentes con VIH

https://clinicalinfo.hiv.gov/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-3

Explore HIV and Immunization Resources for National Immunization Awareness Month

https://clinicalinfo.hiv.gov/news/explore-hiv-and-immunization-resources-national-immunization-awareness-month

Explore el VIH y los recursos de inmunización para el Mes Nacional de Concientización sobre la inmunización

https://clinicalinfo.hiv.gov/news/explore-hiv-and-immunization-resources-national-immunization-awareness-month

Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV

https://clinicalinfo.hiv.gov/news/updates-guidelines-use-antiretroviral-agents-adults-and-adolescents-hiv-2

Actualizaciones a las Guías del Uso de Agentes Antirretrovirales en Adultos y Adolescentes con VIH

https://clinicalinfo.hiv.gov/news/updates-guidelines-use-antiretroviral-agents-adults-and-adolescents-hiv-2

Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children

https://clinicalinfo.hiv.gov/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-hiv-exposed

Actualizaciones a las Guías para la Prevención y el Tratamiento de Infecciones Oportunistas en Niños expuestos e infectados con el VIH

https://clinicalinfo.hiv.gov/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-hiv-exposed

Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

https://clinicalinfo.hiv.gov/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-4

Actualizaciones a las Guías para la Prevención y Tratamiento de Infecciones Oportunistas en Adultos y Adolescentes con VIH

https://clinicalinfo.hiv.gov/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-4

Appendix A. Drug Characteristics Tables

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-characteristics-tables

Smallpox and Mpox Vaccine

https://clinicalinfo.hiv.gov/drugs/smallpox-and-mpox-vaccine/fda-label

Appendix B. Antiretroviral Dosing Recommendations in Adults With Renal or Hepatic Insufficiency

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-characteristics-tables-renal-hepatic-insufficiency-full

Appendix C. Study and Trial Names

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/study-and-trial-names

Appendix A, Table 4. Characteristics of Non-Nucleoside Reverse Transcriptase Inhibitors

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-characteristics-tables-nnrti-full

Smallpox and Mpox Vaccine

https://clinicalinfo.hiv.gov/drugs/smallpox-and-mpox-vaccine/patient

Vacuna contra la viruela y la viruela símica

https://clinicalinfo.hiv.gov/drugs/smallpox-and-mpox-vaccine/patient

Reflections on the AIDS 2022 Global Village

https://clinicalinfo.hiv.gov/news/reflections-aids-2022-global-village